|
1
|
Crimmins EM and Zhang YS: Aging
populations, mortality, and life expectancy. Annu Rev Sociol.
45:annurev–soc-073117-041351. 2019. View Article : Google Scholar
|
|
2
|
Franceschi C, Garagnani P, Morsiani C,
Conte M, Santoro A, Grignolio A, Monti D, Capri M and Salvioli S:
The Continuum of Aging and Age-Related Diseases: Common Mechanisms
but Different Rates. Front Med (Lausanne). 5:612018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ganguli M: Cancer and dementia: It's
complicated. Alzheimer Dis Assoc Disord. 29:177–182.
2015.PubMed/NCBI
|
|
4
|
Behrens MI, Lendon C and Roe CM: A common
biological mechanism in cancer and Alzheimer's disease? Curr
Alzheimer Res. 6:196–204. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Snyder HM, Ahles T, Calderwood S, Carrillo
MC, Chen H, Chang CH, Craft S, De Jager P, Driver JA, Fillit H, et
al: Exploring the nexus of Alzheimer's disease and related
dementias with cancer and cancer therapies: A convening of the
Alzheimer's Association & Alzheimer's Drug Discovery
Foundation. Alzheimers Dement. 13:267–273. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ibáñez K, Boullosa C, Tabarés-Seisdedos R,
Baudot A and Valencia A: Molecular evidence for the inverse
comorbidity between central nervous system disorders and cancers
detected by transcriptomic meta-analyses. PLoS Genet.
10:e10041732014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Trovato Salinaro A, Pennisi M, Di Paola R,
Scuto M, Crupi R, Cambria MT, Ontario ML, Tomasello M, Uva M,
Maiolino L, et al: Neuroinflammation and neurohormesis in the
pathogenesis of Alzheimer's disease and Alzheimer-linked
pathologies: Modulation by nutritional mushrooms. Immun Ageing.
15:82018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pennisi M, Crupi R, Di Paola R, Ontario
ML, Bella R, Calabrese EJ, Crea R, Cuzzocrea S and Calabrese V:
Inflammasomes, hormesis, and antioxidants in neuroinflammation:
Role of NRLP3 in Alzheimer disease. J Neurosci Res. 95:1360–1372.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cornelius C, Trovato Salinaro A, Scuto M,
Fronte V, Cambria MT, Pennisi M, Bella R, Milone P, Graziano A,
Crupi R, et al: Cellular stress response, sirtuins and UCP proteins
in Alzheimer disease: Role of vitagenes. Immun Ageing. 10:412013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vivarelli S, Falzone L, Basile MS,
Nicolosi D, Genovese C, Libra M and Salmeri M: Benefits of using
probiotics as adjuvants in anticancer therapy (Review). World J
Acad Sci June. 1:125–135. 2019.
|
|
11
|
Vivarelli S, Salemi R, Candido S, Falzone
L, Santagati M, Stefani S, Torino F, Banna GL, Tonini G and Libra
M: Gut microbiota and cancer: From pathogenesis to therapy. Cancers
(Basel). 11:E382019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang T, Han Y, Wang J, Hou D, Deng H,
Deng YL and Song Z: Comparative epidemiological Investigation of
Alzheimer's disease and colorectal cancer: The possible role of
gastrointestinal conditions in the pathogenesis of AD. Front Aging
Neurosci. 10:1762018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Banna GL, Torino F, Marletta F, Santagati
M, Salemi R, Cannarozzo E, Falzone L, Ferraù F and Libra M:
Lactobacillus rhamnosus GG: An overview to explore the
rationale of its use in cancer. Front Pharmacol. 8:6032017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lanza G, Bella R, Cantone M, Pennisi G,
Ferri R and Pennisi M: Cognitive impairment and celiac disease: Is
transcranial magnetic stimulation a trait d'Union between gut and
brain? Int J Mol Sci. 19:E22432018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fotakopoulos G, Brotis AG, Kotlia P and
Fountas K: Glioblastoma multiforme in a patient with celiac
disease: Management of seizures after gross total tumor resection.
World Neurosurg. 118:209–211. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pennisi M, Bramanti A, Cantone M, Pennisi
G, Bella R and Lanza G: Neurophysiology of the ‘Celiac Brain’:
Disentangling gut-brain connections. Front Neurosci. 11:4982017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bella R, Lanza G, Cantone M, Giuffrida S,
Puglisi V, Vinciguerra L, Pennisi M, Ricceri R, D'Agate CC,
Malaguarnera G, et al: Effect of a gluten-free diet on cortical
excitability in adults with celiac disease. PLoS One.
10:e01292182015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pennisi G, Lanza G, Giuffrida S,
Vinciguerra L, Puglisi V, Cantone M, Pennisi M, D'Agate CC, Naso P,
Aprile G, et al: Excitability of the motor cortex in de novo
patients with celiac disease. PLoS One. 9:e1027902014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rapisarda V, Ledda C, Matera S, Fago L,
Arrabito G, Falzone L, Marconi A, Libra M and Loreto C: Absence of
t(14;18) chromosome translocation in agricultural workers after
short-term exposure to pesticides. Mol Med Rep. 15:3379–3382. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Garozzo A, Falzone L, Rapisarda V, Marconi
A, Cinà D, Fenga C, Spandidos DA and Libra M: The risk of HCV
infection among health-care workers and its association with
extrahepatic manifestations (Review). Mol Med Rep. 15:3336–3339.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fenga C, Gangemi S, Di Salvatore V,
Falzone L and Libra M: Falzone L amd Libra M: Immunological effects
of occupational exposure to lead (Review). Mol Med Rep.
15:3355–3360. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rapisarda V, Salemi R, Marconi A, Loreto
C, Graziano AC, Cardile V, Basile MS, Candido S, Falzone L,
Spandidos DA, et al: Fluoro-edenite induces fibulin-3
overexpression in non-malignant human mesothelial cells. Oncol
Lett. 12:3363–3367. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Falzone L, Marconi A, Loreto C, Franco S,
Spandidos DA and Libra M: Occupational exposure to carcinogens:
Benzene, pesticides and fibers (Review). Mol Med Rep. 14:4467–4474.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pennisi M, Malaguarnera G, Puglisi V,
Vinciguerra L, Vacante M and Malaguarnera M: Neurotoxicity of
acrylamide in exposed workers. Int J Environ Res Public Health.
10:3843–3854. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Alessandria I, Pennisi M, Cataudella E,
Frazzetto PM, Malaguarnera M and Rampello L and Rampello L:
Neurotoxicity in cadmium-exposed workers. Acta Med Mediter.
28:253–526. 2012.
|
|
26
|
Pennisi M, Lanza G, Cantone M, Schepis C,
Ferri R, Barone R and Bella R: Unusual neurological presentation of
nevoid basal cell carcinoma syndrome (Gorlin-Goltz syndrome). J
Clin Neurol. 13:439–441. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cantone M, Lanza G, Pennisi M, Bella R,
Schepis C, Siragusa M, Barone R and Ferri R: Prominent neurological
involvement in Dercum disease. J Neurol. 264:796–798. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Uccello M, Vacante M, Giordano M,
Malaguarnera M, Biondi A, Basile F, Malaguarnera G, Pennisi M and
Motta M: Osteoblastoma of cervical spine causing an unusual neck
pain. Eur Rev Med Pharmacol Sci. 16 (Suppl 4):17–20.
2012.PubMed/NCBI
|
|
29
|
Sánchez-Valle J, Tejero H, Ibáñez K,
Portero JL, Krallinger M, Al-Shahrour F, Tabarés-Seisdedos R,
Baudot A and Valencia A: A molecular hypothesis to explain direct
and inverse co-morbidities between Alzheimer's disease,
glioblastoma and lung cancer. Sci Rep. 7:44742017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu T, Ren D, Zhu X, Yin Z, Jin G, Zhao Z,
Robinson D, Li X, Wong K, Cui K, et al: Transcriptional signaling
pathways inversely regulated in Alzheimer's disease and
glioblastoma multiform. Sci Rep. 3:34672013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lehrer S: Glioma and Alzheimer's disease.
J Alzheimers Dis Rep. 2:213–218. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Roe CM, Behrens MI, Xiong C, Miller JP and
Morris JC: Alzheimer disease and cancer. Neurology. 64:895–898.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Parsons CG, Danysz W, Dekundy A and Pulte
I: Memantine and cholinesterase inhibitors: Complementary
mechanisms in the treatment of Alzheimer's disease. Neurotox Res.
24:358–369. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hanif F, Muzaffar K, Perveen K, Malhi SM
and Simjee ShU: Glioblastoma multiforme: A review of its
epidemiology and pathogenesis through clinical presentation and
treatment. Asian Pac J Cancer Prev. 18:3–9. 2017.PubMed/NCBI
|
|
35
|
Davis ME: Glioblastoma: Overview of
Disease and Treatment. Clin J Oncol Nurs. 20 (Suppl 5):S2–S8. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Alphandéry E: Glioblastoma Treatments: An
Account of Recent Industrial Developments. Front Pharmacol.
9:8792018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Falzone L, Salomone S and Libra M:
Evolution of cancer pharmacological treatments at the turn of the
third millennium. Front Pharmacol. 9:13002018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Paskaš S, Krajnović T, Basile MS,
Dunđerović D, Cavalli E, Mangano K, Mammana S, Al-Abed Y, Nicoletti
F, Mijatović S, et al: Senescence as a main mechanism of Ritonavir
and Ritonavir-NO action against melanoma. Mol Carcinog. Apr
17–2019.(Epub ahead of print). doi: 10.1002/mc.23020. View Article : Google Scholar
|
|
39
|
Paskas S, Mazzon E, Basile MS, Cavalli E,
Al-Abed Y, He M, Rakocevic S, Nicoletti F, Mijatovic S and
Maksimovic-Ivanic D: Lopinavir-NO, a nitric oxide-releasing HIV
protease inhibitor, suppresses the growth of melanoma cells in
vitro and in vivo. Invest New Drugs. Feb 1–2019.(Epub ahead of
print). doi: 10.1007/s10637-019-00733-3. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Basile MS, Mazzon E, Krajnovic T, Draca D,
Cavalli E, Al-Abed Y, Bramanti P, Nicoletti F, Mijatovic S and
Maksimovic-Ivanic D: Anticancer and differentiation properties of
the nitric oxide derivative of lopinavir in human glioblastoma
cells. Molecules. 23:E24632018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lazarević M, Mazzon E, Momčilović M,
Basile MS, Colletti G, Petralia MC, Bramanti P, Nicoletti F and
Miljković Đ: The H2S donor GYY4137 stimulates reactive
oxygen species generation in BV2 cells while suppressing the
secretion of TNF and nitric oxide. Molecules. 23:E29662018.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Vinciguerra L, Lanza G, Puglisi V, Pennisi
M, Cantone M, Bramanti A, Pennisi G and Bella R: Transcranial
Doppler ultrasound in vascular cognitive impairment-no dementia.
PLoS One. 14:e02161622019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Puglisi V, Bramanti A, Lanza G, Cantone M,
Vinciguerra L, Pennisi M, Bonanno L, Pennisi G and Bella R:
Impaired cerebral haemodynamics in vascular depression: Insights
from transcranial doppler ultrasonography. Front Psychiatry.
9:3162018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lanza G, Bramanti P, Cantone M, Pennisi M,
Pennisi G and Bella R: Vascular cognitive impairment through the
looking glass of transcranial magnetic stimulation. Behav Neurol.
2017:14213262017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pennisi M, Lanza G, Cantone M, Ricceri R,
Spampinato C, Pennisi G, Di Lazzaro V and Bella R: Correlation
between motor cortex excitability changes and cognitive impairment
in vascular depression: Pathophysiological insights from a
longitudinal TMS study. Neural Plast. 2016:81549692016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Concerto C, Lanza G, Cantone M, Pennisi M,
Giordano D, Spampinato C, Ricceri R, Pennisi G, Aguglia E and Bella
R: Different patterns of cortical excitability in major depression
and vascular depression: A transcranial magnetic stimulation study.
BMC Psychiatry. 13:3002013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bella R, Ferri R, Lanza G, Cantone M,
Pennisi M, Puglisi V, Vinciguerra L, Spampinato C, Mazza T,
Malaguarnera G, et al: TMS follow-up study in patients with
vascular cognitive impairment-no dementia. Neurosci Lett.
534:155–159. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Pennisi G, Ferri R, Lanza G, Cantone M,
Pennisi M, Puglisi V, Malaguarnera G and Bella R: Transcranial
magnetic stimulation in Alzheimer's disease: A neurophysiological
marker of cortical hyperexcitability. J Neural Transm (Vienna).
118:587–598. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lanza G, Lanuzza B, Aricò D, Cantone M,
Cosentino FII, Bella R, Pennisi G, Ferri R and Pennisi M: Impaired
short-term plasticity in restless legs syndrome: A pilot rTMS
study. Sleep Med. 46:1–4. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lanza G, Cantone M, Aricò D, Lanuzza B,
Cosentino FII, Paci D, Papotto M, Pennisi M, Bella R, Pennisi G, et
al: Clinical and electrophysiological impact of repetitive
low-frequency transcranial magnetic stimulation on the
sensory-motor network in patients with restless legs syndrome. Ther
Adv Neurol Disorder. 11:17562864187599732018.
|
|
51
|
Lanza G, Cantone M, Lanuzza B, Pennisi M,
Bella R, Pennisi G and Ferri R: Distinctive patterns of cortical
excitability to transcranial magnetic stimulation in obstructive
sleep apnea syndrome, restless legs syndrome, insomnia, and sleep
deprivation. Sleep Med Rev. 19:39–50. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lanza G, Lanuzza B, Aricò D, Cantone M,
Cosentino FI, Pennisi M, Bella R, Pennisi G and Ferri R: Direct
comparison of cortical excitability to transcranial magnetic
stimulation in obstructive sleep apnea syndrome and restless legs
syndrome. Sleep Med. 16:138–142. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Cantone M, Bramanti A, Lanza G, Pennisi M,
Bramanti P, Pennisi G and Bella R: Cortical Plasticity in
Depression. ASN Neuro. 9:17590914177115122017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Pennisi M, Lanza G, Cantone M, Ricceri R,
Ferri R, D'Agate CC, Pennisi G, Di Lazzaro V and Bella R: Cortical
involvement in celiac disease before and after long-term
gluten-free diet: A Transcranial Magnetic Stimulation study. PLoS
One. 12:e01775602017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Lanza G, Bella R, Giuffrida S, Cantone M,
Pennisi G, Spampinato C, Giordano D, Malaguarnera G, Raggi A and
Pennisi M: Preserved transcallosal inhibition to transcranial
magnetic stimulation in nondemented elderly patients with
leukoaraiosis. BioMed Res Int. 2013:3516802013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Spampinato C, Aguglia E, Concerto C,
Pennisi M, Lanza G, Bella R, Cantone M, Pennisi G, Kavasidis I and
Giordano D: Transcranial magnetic stimulation in the assessment of
motor cortex excitability and treatment of drug-resistant major
depression. IEEE Trans Neural Syst Rehabil Eng. 21:391–403. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Presti M, Mazzon E, Basile MS, Petralia
MC, Bramanti A, Colletti G, Bramanti P, Nicoletti F and Fagone P:
Overexpression of macrophage migration inhibitory factor and
functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in
glioblastoma. Oncol Lett. 16:2881–2886. 2018.PubMed/NCBI
|
|
58
|
Mammana S, Fagone P, Cavalli E, Basile MS,
Petralia MC, Nicoletti F, Bramanti P and Mazzon E: The role of
macrophages in neuroinflammatory and neurodegenerative pathways of
Alzheimer's disease, amyotrophic lateral sclerosis, and multiple
sclerosis: Pathogenetic cellular effectors and potential
therapeutic targets. Int J Mol Sci. 19:E8312018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Mangano K, Mazzon E, Basile MS, Di Marco
R, Bramanti P, Mammana S, Petralia MC, Fagone P and Nicoletti F:
Pathogenic role for macrophage migration inhibitory factor in
glioblastoma and its targeting with specific inhibitors as novel
tailored therapeutic approach. Oncotarget. 9:17951–17970. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Nicoletti F, Mazzon E, Fagone P, Mangano
K, Mammana S, Cavalli E, Basile MS, Bramanti P, Scalabrino G, Lange
A, et al: Prevention of clinical and histological signs of
MOG-induced experimental allergic encephalomyelitis by prolonged
treatment with recombinant human EGF. J Neuroimmunol. 332:224–232.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Ludwig K and Kornblum HI: Molecular
markers in glioma. J Neurooncol. 134:505–512. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Maniati MS, Maniati M, Yousefi T,
Ahmadi-Ahangar A and Tehrani SS: New insights into the role of
microRNAs and long noncoding RNAs in most common neurodegenerative
diseases. J Cell Biochem. 120:8908–8918. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Battaglia R, Palini S, Vento ME, La
Ferlita A, Lo Faro MJ, Caroppo E, Borzì P, Falzone L, Barbagallo D,
Ragusa M, et al: Identification of extracellular vesicles and
characterization of miRNA expression profiles in human blastocoel
fluid. Sci Rep. 9:842019. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Falzone L, Lupo G, Rosa GRM, Crimi S,
Anfuso CD, Salemi R, Rapisarda E, Libra M and Candido S:
Identification of novel MicroRNAs and their diagnostic and
prognostic significance in oral cancer. Cancers (Basel).
11:E6102019. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Hafsi S, Candido S, Maestro R, Falzone L,
Soua Z, Bonavida B, Spandidos DA and Libra M: Correlation between
the overexpression of Yin Yang 1 and the expression levels of
miRNAs in Burkitt's lymphoma: A computational study. Oncol Lett.
11:1021–1025. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Falzone L, Scola L, Zanghì A, Biondi A, Di
Cataldo A, Libra M and Candido S: Integrated analysis of colorectal
cancer microRNA datasets: Identification of microRNAs associated
with tumor development. Aging (Albany NY). 10:1000–1014. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Falzone L, Candido S, Salemi R, Basile MS,
Scalisi A, McCubrey JA, Torino F, Signorelli SS, Montella M and
Libra M: Computational identification of microRNAs associated to
both epithelial to mesenchymal transition and NGAL/MMP-9 pathways
in bladder cancer. Oncotarget. 7:72758–72766. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Kozomara A, Birgaoanu M and
Griffiths-Jones S: miRBase: From microRNA sequences to function.
Nucleic Acids Res. 47:D155–D162. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Vlachos IS, Zagganas K, Paraskevopoulou
MD, Georgakilas G, Karagkouni D, Vergoulis T, Dalamagas T and
Hatzigeorgiou AG: DIANA-miRPath v3.0: Deciphering microRNA function
with experimental support. Nucleic Acids Res. 43:W460–W466. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Falzone L, Romano GL, Salemi R, Bucolo C,
Tomasello B, Lupo G, Anfuso CD, Spandidos DA, Libra M and Candido
S: Prognostic significance of deregulated microRNAs in uveal
melanomas. Mol Med Rep. 19:2599–2610. 2019.PubMed/NCBI
|
|
71
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Nixon DW: The inverse relationship between
cancer and Alzheimer's disease: A possible mechanism. Curr
Alzheimer Res. 14:883–893. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Shafi O: Inverse relationship between
Alzheimer's disease and cancer, and other factors contributing to
Alzheimer's disease: A systematic review. BMC Neurol. 16:2362016.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Park S, Yu SJ, Cho Y, Balch C, Lee J, Kim
YH and Nam S: Network comparison of inflammation in colorectal
cancer and Alzheimer's disease. BioMed Res Int. 2015:2052472015.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Godlewski J, Lenart J and Salinska E:
MicroRNA in brain pathology: Neurodegeneration the other side of
the brain cancer. Noncoding RNA. 5:E202019.PubMed/NCBI
|
|
76
|
Ham S, Kim TK, Ryu J, Kim YS, Tang YP and
Im HI: Comprehensive MicroRNAome analysis of the relationship
between Alzheimer disease and cancer in PSEN double-knockout mice.
Int Neurourol J. 22:237–245. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Polo A, Crispo A, Cerino P, Falzone L,
Candido S, Giudice A, De Petro G, Ciliberto G, Montella M, Budillon
A, et al: Environment and bladder cancer: Molecular analysis by
interaction networks. Oncotarget. 8:65240–65252. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
McCubrey JA, Fitzgerald TL, Yang LV,
Lertpiriyapong K, Steelman LS, Abrams SL, Montalto G, Cervello M,
Neri LM, Cocco L, et al: Roles of GSK-3 and microRNAs on epithelial
mesenchymal transition and cancer stem cells. Oncotarget.
8:14221–14250. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Jesionek-Kupnicka D, Braun M,
Trąbska-Kluch B, Czech J, Szybka M, Szymańska B, Kulczycka-Wojdala
D, Bieńkowski M, Kordek R and Zawlik I: MiR-21, miR-34a, miR-125b,
miR-181d and miR-648 levels inversely correlate with MGMT and TP53
expression in primary glioblastoma patients. Arch Med Sci.
15:504–512. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
ParvizHamidi M, Haddad G, Ostadrahimi S,
Ostadrahimi N, Sadeghi S, Fayaz S and Fard-Esfahani P: Circulating
miR-26a and miR-21 as biomarkers for glioblastoma multiform.
Biotechnol Appl Biochem. 66:261–265. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Wu W, Yu T, Wu Y, Tian W, Zhang J and Wang
Y: The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma
growth and progression. J Exp Clin Cancer Res. 38:1332019.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Yin CY, Kong W, Jiang J, Xu H and Zhao W:
miR-7-5p inhibits cell migration and invasion in glioblastoma
through targeting SATB1. Oncol Lett. 17:1819–1825. 2019.PubMed/NCBI
|
|
83
|
Choi JY, Shin HJ and Bae IH: miR-93-5p
suppresses cellular senescence by directly targeting Bcl-w and p21.
Biochem Biophys Res Commun. 505:1134–1140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Shi L, Yuan Y and Li HY: MicroRNA-139-3p
suppresses growth and metastasis of glioblastoma via inhibition of
NIN1/RPNI2 binding protein 1 homolog. Eur Rev Med Pharmacol Sci.
23:4264–4274. 2019.PubMed/NCBI
|
|
85
|
Zeng A, Yin J, Li Y, Li R, Wang Z, Zhou X,
Jin X, Shen F, Yan W and You Y: miR-129-5p targets Wnt5a to block
PKC/ERK/NF-κB and JNK pathways in glioblastoma. Cell Death Dis.
9:3942018. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Xu H, Hu Y and Qiu W: Potential mechanisms
of microRNA-129-5p in inhibiting cell processes including
viability, proliferation, migration and invasiveness of
glioblastoma cells U87 through targeting FNDC3B. Biomed
Pharmacother. 87:405–411. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Shan ZN, Tian R, Zhang M, Gui ZH, Wu J,
Ding M, Zhou XF and He J: miR128-1 inhibits the growth of
glioblastoma multiforme and glioma stem-like cells via targeting
BMI1 and E2F3. Oncotarget. 7:78813–78826. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Wu Y, Xu J, Xu J, Cheng J, Jiao D, Zhou C,
Dai Y and Chen Q: Lower serum levels of miR-29c-3p and miR-19b-3p
as biomarkers for Alzheimer's disease. Tohoku J Exp Med.
242:129–136. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Yang G, Song Y, Zhou X, Deng Y, Liu T,
Weng G, Yu D and Pan S: MicroRNA-29c targets β-site amyloid
precursor protein-cleaving enzyme 1 and has a neuroprotective role
in vitro and in vivo. Mol Med Rep. 12:3081–3088.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Lei X, Lei L, Zhang Z, Zhang Z and Cheng
Y: Downregulated miR-29c correlates with increased BACE1 expression
in sporadic Alzheimer's disease. Int J Clin Exp Pathol.
8:1565–1574. 2015.PubMed/NCBI
|
|
91
|
Zong Y, Yu P, Cheng H, Wang H, Wang X,
Liang C, Zhu H, Qin Y and Qin C: miR-29c regulates NAV3 protein
expression in a transgenic mouse model of Alzheimer's disease.
Brain Res. 1624:95–102. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Wang Y, Li Y, Sun J, Wang Q, Sun C, Yan Y,
Yu L, Cheng D, An T, Shi C, et al: Tumor-suppressive effects of
miR-29c on gliomas. Neuroreport. 24:637–645. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Song K, Yuan Y, Lin Y, Wang YX, Zhou J,
Gai QJ, Zhang L, Mao M, Yao XX, Qin Y, et al: ERBB3, IGF1R, and
TGFBR2 expression correlate with PDGFR expression in glioblastoma
and participate in PDGFR inhibitor resistance of glioblastoma
cells. Am J Cancer Res. 8:792–809. 2018.PubMed/NCBI
|
|
94
|
Salemi R, Falzone L, Madonna G, Polesel J,
Cinà D, Mallardo D, Ascierto PA, Libra M and Candido S: MMP-9 as a
candidate marker of response to BRAF inhibitors in melanoma
patients with BRAFV600E mutation detected in circulating-free DNA.
Front Pharmacol. 9:8562018. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Leonardi GC, Falzone L, Salemi R, Zanghì
A, Spandidos DA, Mccubrey JA, Candido S and Libra M: Cutaneous
melanoma: From pathogenesis to therapy (Review). Int J Oncol.
52:1071–1080. 2018.PubMed/NCBI
|
|
96
|
Guarneri C, Bevelacqua V, Polesel J,
Falzone L, Cannavò PS, Spandidos DA, Malaponte G and Libra M: NF-κB
inhibition is associated with OPN/MMP 9 downregulation in cutaneous
melanoma. Oncol Rep. 37:737–746. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Weber GL, Parat MO, Binder ZA, Gallia GL
and Riggins GJ: Abrogation of PIK3CA or PIK3R1 reduces
proliferation, migration, and invasion in glioblastoma multiforme
cells. Oncotarget. 2:833–849. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Hardy J: The discovery of
Alzheimer-causing mutations in the APP gene and the formulation of
the ‘amyloid cascade hypothesis’. FEBS J. 284:1040–1044. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Ochalek A, Mihalik B, Avci HX,
Chandrasekaran A, Téglási A, Bock I, Giudice ML, Táncos Z, Molnár
K, László L, et al: Neurons derived from sporadic Alzheimer's
disease iPSCs reveal elevated TAU hyperphosphorylation, increased
amyloid levels, and GSK3B activation. Alzheimers Res Ther.
9:902017. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Cadonic C, Sabbir MG and Albensi BC:
Mechanisms of mitochondrial dysfunction in Alzheimer's disease. Mol
Neurobiol. 53:6078–6090. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Shinohara M, Tachibana M, Kanekiyo T and
Bu G: Role of LRP1 in the pathogenesis of Alzheimer's disease:
Evidence from clinical and preclinical studies. J Lipid Res.
58:1267–1281. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Falzone L, Salemi R, Travali S, Scalisi A,
McCubrey JA, Candido S and Libra M: MMP-9 overexpression is
associated with intragenic hypermethylation of MMP9 gene in
melanoma. Aging (Albany NY). 8:933–944. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Mastroeni D, Grover A, Delvaux E,
Whiteside C, Coleman PD and Rogers J: Epigenetic mechanisms in
Alzheimer's disease. Neurobiol Aging. 32:1161–1180. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Wang Z, He C and Shi JS: Natural products
for the treatment of neurodegenerative diseases. Curr Med Chem. May
27–2019.(Epub ahead of print). doi:
10.2174/0929867326666190527120614. View Article : Google Scholar :
|
|
105
|
Lanza G, Centonze SS, Destro G, Vella V,
Bellomo M, Pennisi M, Bella R and Ciavardelli D: Comment on
‘Shiatsu as an adjuvant therapy for depression in patients with
Alzheimer's disease: A Pilot Study’. J Evid Based Integr Med.
24:2515690X188251052019. View Article : Google Scholar :
|
|
106
|
Lanza G, Centonze SS, Destro G, Vella V,
Bellomo M, Pennisi M, Bella R and Ciavardelli D: Shiatsu as an
adjuvant therapy for depression in patients with Alzheimer's
disease: A pilot study. Complement Ther Med. 38:74–78. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Calabrese V, Dattilo S, Petralia A,
Parenti R, Pennisi M, Koverech G, Calabrese V, Graziano A, Monte I,
Maiolino L, et al: Analytical approaches to the diagnosis and
treatment of aging and aging-related disease: Redox status and
proteomics. Free Radic Res. 49:511–524. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Giordano D, Kavasidis I, Spampinato C,
Bella R, Pennisi G and Pennisi M: An integrated computer-controlled
system for assisting researchers in cortical excitability studies
by using transcranial magnetic stimulation. Comput Methods Programs
Biomed. 107:4–15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Pennisi G, Ferri R, Cantone M, Lanza G,
Pennisi M, Vinciguerra L, Malaguarnera G and Bella R: A review of
transcranial magnetic stimulation in vascular dementia. Dement
Geriatr Cogn Disord. 31:71–80. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Faro A, Giordano D, Kavasidis I, Pino C,
Spampinato C, Cantone GM, Lanza G and Pennisi M: An Interactive
Tool for Customizing Clinical Transacranial Magnetic Stimulation
(TMS) Experiments. XII Mediterranean Conference on Medical and
Biological Engineering and Computing. 200–203. 2010.
|
|
111
|
Faro A, Giordano D, Pennisi M, Scarciofalo
G, Spampinato C and Tramontana F: Transcranial Magnetic Stimulation
(TMS) to Evaluate and Classify Mental Diseases Using Neural
Networks. Conference on Artificial Intelligence in Medicine in
Europe AIME Artificial Intelligence in Medicine. 310–314. 2005.
|
|
112
|
Zhang W, Zhang J, Hoadley K, Kushwaha D,
Ramakrishnan V, Li S, Kang C, You Y, Jiang C, Song SW, et al:
miR-181d: A predictive glioblastoma biomarker that downregulates
MGMT expression. Neuro Oncol. 14:712–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Chen L, Zhang W, Yan W, Han L, Zhang K,
Shi Z, Zhang J, Wang Y, Li Y, Yu S, et al: The putative tumor
suppressor miR-524-5p directly targets Jagged-1 and Hes-1 in
glioma. Carcinogenesis. 33:2276–2282. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Jones TA, Jeyapalan JN, Forshew T,
Tatevossian RG, Lawson AR, Patel SN, Doctor GT, Mumin MA, Picker
SR, Phipps KP, et al: Molecular analysis of pediatric brain tumors
identifies microRNAs in pilocytic astrocytomas that target the MAPK
and NF-κB pathways. Acta Neuropathol Commun. 3:862015. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Shigemizu D, Akiyama S, Asanomi Y,
Boroevich KA, Sharma A, Tsunoda T, Matsukuma K, Ichikawa M, Sudo H,
Takizawa S, et al: Risk prediction models for dementia constructed
by supervised principal component analysis using miRNA expression
data. Commun Biol. 2:772019. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Nunez-Iglesias J, Liu CC, Morgan TE, Finch
CE and Zhou XJ: Joint genome-wide profiling of miRNA and mRNA
expression in Alzheimer's disease cortex reveals altered miRNA
regulation. PLoS One. 5:e88982010. View Article : Google Scholar : PubMed/NCBI
|
